Literature DB >> 12602841

Hemochromatosis. More common than you think.

Mark Ram Borgaonkar1.   

Abstract

OBJECTIVE: To review current knowledge of the genetics, presentation, diagnosis, and management of hereditary hemochromatosis. QUALITY OF EVIDENCE: MEDLINE was searched from January 1966 to June 2002, and references of relevant papers were reviewed. Most articles were reviews, practice guidelines, or observational studies. Several randomized controlled trials were identified but none studied primary therapy for hemochromatosis. MAIN MESSAGE: Hemochromatosis, the most common genetic disease in white populations, has a prevalence of one in 200, yet is still underrecognized. This disease of unregulated iron absorption leads to generalized iron overload that can eventually impair organ systems and lead to cirrhosis, diabetes, and cardiomyopathy. Symptoms are often nonspecific and patients are identified by mild abnormalities in routine laboratory testing. Transferrin saturation, ferritin levels, and genotyping can often establish the diagnosis. Iron depletion therapy with phlebotomy is helpful if initiated before organ damage occurs.
CONCLUSION: Family physicians should be aware that hemochromatosis can be treated effectively if diagnosed early.

Entities:  

Mesh:

Year:  2003        PMID: 12602841      PMCID: PMC2214116     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  43 in total

1.  Use of blood therapeutically drawn from hemochromatosis patients. Council on Scientific Affairs, American Medical Association.

Authors:  L Tan; M K Khan; J C Hawk
Journal:  Transfusion       Date:  1999-09       Impact factor: 3.157

2.  Diagnosis and management of hemochromatosis.

Authors:  A S Tavill
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

3.  Molecular medicine and hemochromatosis: at the crossroads.

Authors:  B R Bacon; L W Powell; P C Adams; T F Kresina; J H Hoofnagle
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

Review 4.  Surveillance for hepatocellular carcinoma.

Authors:  M Sherman
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

5.  Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.

Authors:  P C Adams; L S Valberg
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

6.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

7.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

8.  A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment.

Authors:  S M McDonnell; B L Preston; S A Jewell; J C Barton; C Q Edwards; P C Adams; R Yip
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

9.  Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.

Authors:  Linda M Fletcher; Jeannette L Dixon; David M Purdie; Lawrie W Powell; Darrell H G Crawford
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

10.  Long term results of venesection therapy in idiopathic haemochromatosis.

Authors:  A Bomford; R Williams
Journal:  Q J Med       Date:  1976-10
View more
  4 in total

1.  Factors affecting the body mass index, haemoglobin and serum ferritin level in students.

Authors:  Niaz Hussain Jamali; Abdul Hakeem Jamali; Aftab Ahmed Khand; Hidayatullah Mahesar; Muhammad Iqbal Arain
Journal:  Am J Blood Res       Date:  2017-06-15

2.  Hereditary hemochromatosis: a literature review and case report.

Authors:  Mary K Allen
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

3.  General hyperpigmentation induced by Grave's disease: A case report.

Authors:  Xiaoxiao Song; Yimin Shen; Ying Zhou; Qinhua Lou; Li Han; Jon Kee Ho; Yuezhong Ren
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.

Authors:  Dennis R Lim; Gokul Vidyasankar; Chai Phua; Mark Borgaonkar
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.